Electrochemotherapy treatment improves quality of life

What We Do Find out more

For over 12 years, through a commitment to research and innovation IGEA has partnered with leading scientific institutions across Europe and developed an innovative approach to treating cutaneous and sub-cutaneous tumours (cancers affecting the skin and below the skin’s surface) via the technique of clinical electroporation and electrochemotherapy using the IGEA CLINIPORATOR™ device.

Our Aims & Objectives Find out more

We are passionate about communicating the therapy benefits to health care practitioners in order to expand treatment options for patients when other treatment options are exhausted or not possible.

Locations all over the UK Find a location near you

For over 12 years, through a commitment to research and innovation IGEA has partnered with leading scientific institutions across Europe and developed an innovative approach to treating cutaneous and sub-cutaneous tumours (cancers affecting the skin and below the skin’s surface) via the technique of clinical electroporation and electrochemotherapy using the IGEA CLINIPORATOR™ device.

Electrochemotherapy Satellite Symposium at the 38th ESSO Congress. Budapest, 10-12 October 2018 Latest news

The 38th Congress of the European Society of Surgical Oncology will take place from 10-12 October 2018 in Budapest, Hungary. Focusing on bridging the disparity between minimum standards of care across Europe, the overarching theme of the Congress is ‘Better outcome with Innovative Surgery’.

ESSO Meet the Expert Webinar: Electrochemotherapy. Online, 14 June 2018 Latest news

Prof. Ibrahim Edhemovic will present this ESSO Webinar on Thursday 14th June at 19:00 CET (Brussels time). Co-speakers are Prof. Gregor Sersa and Dr. Erik Brecelj, both from Institute of Oncology Ljubljana, Ljubljana, SI.

© Copyright 2015 IGEA Clinical Biophysics. All rights reserved.